Vietnam aims to domestically produce 15 vaccines by 2030
Hanoi, Vietnam - The nation has accelerated its timeline for mastering the technology to produce multiple types of vaccines, aiming to achieve this by 2030. Initially, the goal was set for 2025, but has now been moved up by five years.
Under the revised National Programme to Ensure Vaccine Supply for Immunization through 2030, Vietnam targets the ability to produce 15 types of vaccines domestically. These vaccines will be manufactured to meet international quality standards.
Previously, Vietnam aimed to master the production technology for ten vaccine types by 2025 and the capability to produce at least three of them, including a combination 5-in-1 vaccine that shields against diphtheria, pertussis (whooping cough), tetanus, Haemophilus influenzae type B (Hib), and either polio or hepatitis B.
By 2030, the country aspires to have mastered the production technology for 15 vaccine types, and to successfully produce at least five of these vaccines.
Deputy Prime Minister Le Thanh Long signed Decision No 1018/QĐ-TTg, amending and supplementing Decision No. 1286/QĐ-TTg of October 25, 2022. This decision approves the updated vaccine program and pushes forward the 2025 milestone.
The Ministry of Health has been tasked with coordinating with other ministries and relevant agencies to quickly develop a detailed plan for the production of these vaccines. The plan should encompass a clear implementation roadmap and be submitted to the Prime Minister by the third quarter of 2026.
Covivac, a COVID-19 vaccine developed by the Institute of Vaccines and Medical Biologicals (IVAC). VNA/VNS Photo
This initiative is part of Vietnam's wider strategy to ensure self-sufficiency in vaccine production and bolster its healthcare capabilities. The country aims to master the production technology for 30 vaccine types by 2030, enhancing its independence from foreign vaccine supplies.
In alignment with Vietnam's enhanced health-and-wellness strategy, the country aims to master the production technology for 30 vaccine types by 2030, reinforcing its independence from foreign vaccine supplies. By 2030, the country aspires to not only have mastered the production technology for 15 vaccine types, and to successfully produce at least five of these vaccines, but also to produce these vaccines to meet international quality standards. The Ministry of Health, coordinating with other ministries and relevant agencies, is tasked with developing a detailed plan for the production of these vaccines, encompassing a clear implementation roadmap and submitting it to the Prime Minister by the third quarter of 2026. This comprehensive plan is a crucial step towards Vietnam's ambition of self-sufficiency in vaccine production and strengthening its healthcare capabilities.
